-100
NPS Score
VS
Intarcia Therapeutics
- EMPLOYEE
PARTICIPANTS - 3
- TOTAL
RATINGS
Sarepta Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 34
- TOTAL
RATINGS
Intarcia Therapeutics vs Sarepta Therapeutics
Compare Intarcia Therapeutics versus Sarepta Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 3 employees and customers of Intarcia Therapeutics and 34 employees and customers of Sarepta Therapeutics.
Intarcia Therapeutics
Intarcia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intarcia Therapeutics. Their current valuation is $6.50B.
Sarepta Therapeutics
Sarepta Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Sarepta Therapeutics. Their current market cap is $11.66B.
1.5/5
Product Quality
3.7/5
1.5/5
Pricing
3.7/5
1.5/5
Customer Service
5/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 100% | Detractors |
-9
NPS Score
| 36% | Promoters |
|---|---|
| 19% | Passive |
| 45% | Detractors |
Net Promoter Score
Winner by 91
See how Intarcia Therapeutics compares to its competitors
See how Sarepta Therapeutics compares to its competitors
Working at Intarcia Therapeutics vs Working at Sarepta Therapeutics
73 / 100
CEO Rating
79 / 100
CEO Rating
Winner by 6%
Intarcia Therapeutics
Intarcia Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Sarepta Therapeutics
Employees at Sarepta Therapeutics rate their CEO, Douglas Ingram, 79/100. This score is 6% higher than the scores of Intarcia Therapeutics' CEO, Kurt Graves.